NRX Pharmaceuticals Inc (NASDAQ:NRXP) price on Thursday, March 28, fall -2.92% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.51.
A look at the stock’s price movement, the level at last check in today’s session was $0.53. The beta value (5-Year monthly) was 0.99. Turning to its 52-week performance, $1.20 and $0.22 were the 52-week high and 52-week low respectively. Overall, NRXP moved 68.80% over the past month.
NRX Pharmaceuticals Inc’s market cap currently stands at around $47.56 million, with investors looking forward to this quarter’s earnings report slated for Mar 28, 2024. Analysts project the company’s earnings per share (EPS) to be -$0.07, which has seen fiscal year 2023 EPS growth forecast to increase to -$0.37 and about -$0.26 for fiscal year 2024. Per the data, EPS growth is expected to be 39.30% for 2024 and 29.70% for the next financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that NRXP is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
NRXP’s current price about -2.26% and 10.88% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 51.47, while 7-day volatility ratio is 11.41% and 16.79% in the 30-day chart. Further, NRX Pharmaceuticals Inc (NRXP) has a beta value of 1.04, and an average true range (ATR) of 0.07.
If we refocus on NRX Pharmaceuticals Inc (NASDAQ:NRXP), historical trading data shows that trading volumes averaged 1.17 million over the past 10 days and 1.47 million over the past 3 months. The company’s latest data on shares outstanding shows there are 66.44 million shares.
The 33.38% of NRX Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 4.35% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.71 million on Mar 15, 2024, giving us a short ratio of 1.31. The data shows that as of Mar 15, 2024 short interest in NRX Pharmaceuticals Inc (NRXP) stood at 4.02% of shares outstanding, with shares short falling to 3.87 million registered in Feb 15, 2024. Current price change has pushed the stock 11.85% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NRXP stock continues to rise going into the next quarter.
